News
-
-
PRESS RELEASE
AltaThera Pharmaceuticals at AF Symposium 2024
AltaThera Pharmaceuticals will present data on Sotalol IV, a treatment that may significantly shorten hospital stays for heart-related illnesses at the 29th Annual AF Symposium in Boston from February 1-3. The presentation will feature insights from the PEAKS Registry by Dr. T. Jared Bunch, an esteemed figure in the field of electrophysiology -
-
PRESS RELEASE
Concord(R) Partners With Malaysia’s PCSS Consultancy to Bring Cutting-Edge Capital Project Management and AWP Training to the Asia Pacific Region
Concord® Academy partners with PCSS Consultancy to offer Advanced Work Packaging (AWP) online training to Asia Pacific professionals, aiming to certify thousands of project managers in the region -
-
-
PRESS RELEASE
MOBICARD Revolutionizes Business Cards
Peer To Peer Network introduces MOBICARD™ 1.5, a dynamic digital footprint virtual business card with social media sharing and powerful data analytics for lead-generation intelligence. The groundbreaking platform revolutionizes professional networking with customizable designs, real-time response push notifications, and intuitive analytics -
REGULATED PRESS RELEASE
Eiffage wins the contract for the renovation of the ‘Cristallis’ project in Paris, for an amount of €92 million
Eiffage's subsidiary Eiffage Construction secures €92 million contract for comprehensive renovation of 'Cristallis' project in Paris, including environmental and digital goals and expected completion by end of 2025 -
PRESS RELEASE
EQS-Adhoc: Vita 34 publishes preliminary figures on the course of business in 2023
Vita 34 AG publishes preliminary figures on the course of business in 2023, reporting Group revenue of EUR 76.8 million and preliminary EBITDA of EUR 4.0 million, which fell short of expectations due to extraordinary charges. The company plans to invest in cell and gene therapies and CDMO following the merger with PBKM -
PRESS RELEASE
Halfords Group PLC: Total Voting Rights
Halfords Group PLC announces its total voting rights as at the date of the announcement, with the registered share capital consisting of 218,928,736 ordinary shares. Shareholders may use this figure to determine their notification requirements under the FCA's Disclosure Guidance and Transparency Rules
